![Frontiers | The Safety, Immunogenicity, and Immunopersistence of Hepatitis A Vaccine in HBs-Ag-Positive Participants: A Retrospective Study Frontiers | The Safety, Immunogenicity, and Immunopersistence of Hepatitis A Vaccine in HBs-Ag-Positive Participants: A Retrospective Study](https://www.frontiersin.org/files/Articles/672221/fcimb-11-672221-HTML/image_m/fcimb-11-672221-g001.jpg)
Frontiers | The Safety, Immunogenicity, and Immunopersistence of Hepatitis A Vaccine in HBs-Ag-Positive Participants: A Retrospective Study
![Vaccination at the forefront of the fight against hepatitis B and C | Nature Reviews Gastroenterology & Hepatology Vaccination at the forefront of the fight against hepatitis B and C | Nature Reviews Gastroenterology & Hepatology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41575-021-00570-x/MediaObjects/41575_2021_570_Fig1_HTML.png)
Vaccination at the forefront of the fight against hepatitis B and C | Nature Reviews Gastroenterology & Hepatology
![Immunogenicity and safety of a 2-dose hepatitis B vaccine, HBsAg/CpG 1018, in persons with diabetes mellitus aged 60–70 years - ScienceDirect Immunogenicity and safety of a 2-dose hepatitis B vaccine, HBsAg/CpG 1018, in persons with diabetes mellitus aged 60–70 years - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0264410X19310448-ga1.jpg)
Immunogenicity and safety of a 2-dose hepatitis B vaccine, HBsAg/CpG 1018, in persons with diabetes mellitus aged 60–70 years - ScienceDirect
![Prevention of Hepatitis A Through Active or Passive Immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Prevention of Hepatitis A Through Active or Passive Immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP)](https://www.cdc.gov/mmwr/preview/mmwrhtml/figures/r507a1t3.gif)
Prevention of Hepatitis A Through Active or Passive Immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Observational Study of Vaccine Efficacy 24 Years after the Start of Hepatitis B Vaccination in Two Gambian Villages: No Need for a Booster Dose | PLOS ONE
![Figure 1 from Single-Dose Hepatitis A Immunization: 7.5-Year Observational Pilot Study in Nicaraguan Children to Assess Protective Effectiveness and Humoral Immune Memory Response. | Semantic Scholar Figure 1 from Single-Dose Hepatitis A Immunization: 7.5-Year Observational Pilot Study in Nicaraguan Children to Assess Protective Effectiveness and Humoral Immune Memory Response. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/37f5a5ff7e1d29fcc3c7f4a7b7f939a8621a7676/3-Figure1-1.png)
Figure 1 from Single-Dose Hepatitis A Immunization: 7.5-Year Observational Pilot Study in Nicaraguan Children to Assess Protective Effectiveness and Humoral Immune Memory Response. | Semantic Scholar
![Individual immune responses to a challenge dose of hepatitis A or/and... | Download Scientific Diagram Individual immune responses to a challenge dose of hepatitis A or/and... | Download Scientific Diagram](https://www.researchgate.net/publication/314651177/figure/tbl1/AS:669016997756939@1536517490370/Individual-immune-responses-to-a-challenge-dose-of-hepatitis-A-or-and-hepatitis-B-vaccine.png)
Individual immune responses to a challenge dose of hepatitis A or/and... | Download Scientific Diagram
![Residual risk of mother-to-child transmission of hepatitis B virus infection despite timely birth-dose vaccination in Cameroon (ANRS 12303): a single-centre, longitudinal observational study - The Lancet Global Health Residual risk of mother-to-child transmission of hepatitis B virus infection despite timely birth-dose vaccination in Cameroon (ANRS 12303): a single-centre, longitudinal observational study - The Lancet Global Health](https://www.thelancet.com/cms/asset/74566dd8-e515-4af0-90a8-9543a6b89f3a/gr1.gif)